CLICK HERE to find out more information
This link will take you to a promotional website where MSD/AstraZeneca products will be mentioned
This is a promotional event organised and funded by MSD and AstraZeneca.
This meeting is for UK healthcare professionals only, where MSD/AstraZeneca products will be discussed.
Please consult the SmPC for further information to minimise the risks associated with the use of the medicine before making any prescribing decisions.
Click here for UK Prescribing Information.
Adverse events should be reported. Reporting forms and information can be found at https://yellowcard.mhra.gov.uk/ or search for MHRA Yellow Card in the Google Play orApple App Store. Adverse events should also be reported to AstraZeneca by visiting https://contactazmedical.astrazeneca.com or by calling 0800 783 0033
aOC, advanced ovarian cancer; CPD, continuing professional development; SmPC, Summary of Product Characteristics.
- Lynparza (olaparib). Summary of Product Characteristics. Available at: https://www.medicines.org.uk/emc/product/9488/smpc#gref.Accessed September 2025
